Characteristics of AML patients
| Characteristic . | Value . |
|---|---|
| Patients, n | 31 |
| Age, y | |
| Median | 53 |
| Range | 1-68 |
| Cytogenetics, n (%) | |
| Standard risk | 13 (42) |
| High risk* | 18 (58) |
| Previous HSCT, n (%) | 7 (23) |
| Disease status, n (%) | |
| Primary induction failure | 14 (45) |
| < 2 relapses | 10 (32) |
| ≥ 2 relapses | 7 (23) |
| Antecedent MDS | 8 (26) |
| BM blasts, % | |
| Mean | 30 |
| Range | 0-91 |
| PB blasts, %† | |
| Mean | 16 |
| Range | 1-90 |
| Characteristic . | Value . |
|---|---|
| Patients, n | 31 |
| Age, y | |
| Median | 53 |
| Range | 1-68 |
| Cytogenetics, n (%) | |
| Standard risk | 13 (42) |
| High risk* | 18 (58) |
| Previous HSCT, n (%) | 7 (23) |
| Disease status, n (%) | |
| Primary induction failure | 14 (45) |
| < 2 relapses | 10 (32) |
| ≥ 2 relapses | 7 (23) |
| Antecedent MDS | 8 (26) |
| BM blasts, % | |
| Mean | 30 |
| Range | 0-91 |
| PB blasts, %† | |
| Mean | 16 |
| Range | 1-90 |